Stockreport

Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF On December 4, 2025, Trevi Therapeutics, Inc. (NASDAQ:TRVI) announced the appointment of David Hastings as Chief Financial Officer, effective January 6, 2026. This mark [Read more]